Blopress Tablets specified drug-use survey Hypertension: Survey on patients with metabolic syndrome
- Conditions
- Hypertension
- Registration Number
- JPRN-jRCT1080222516
- Lead Sponsor
- TAKEDA PHARMACEUTICAL COMPANY LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 15000
Hypertensive patients with at least one of the following risk factors:
- Waist circumference >= 85 cm for male and >= 90 cm for female
- Fasting triglyceride level >= 150 mg/dL
- High-density lipoprotein (HDL) cholesterol level < 40 mg/dL
- Fasting blood glucose level >= 110 mg/dL
- Body-mass index (BMI) >= 25.0
*Patients currently taking medications for hypertriglyceridemia, hypo-HDL-cholesterolemia, or diabetes mellitus are also regarded as meeting the criteria for inclusion in the surveillance
Hypertensive patients who meet all of the following conditions ([1] to [3]):
[1] Patients receiving continuous therapy with Blopress Tablets
[2] Patients aged < 20 years or >= 75 years
[3] Patients with a history of cerebrovascular or coronary artery disease within 6 months before the start of the surveillance
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method